Work

379 Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune checkpoint inhibitors: A United States population-level analysis

Year: 2021

Type: article

Study design: Observational Study

Source: Journal of Investigative Dermatology

DOI: 10.1016/j.jid.2021.02.401

Authors: S. Wongvibulsin, V. Pahalyants, M. Kalinich, W. Murphy, K. Yu, F. Wang, S. Chen, K. Reynolds, S.G. Kwatra, Y. Semenov

Institutions: Johns Hopkins University, Massachusetts General Hospital, Harvard University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3155403201

FWCI: 0.328

Cites:

Cited by: 5

Related to: 10